rss
Ann Rheum Dis 1997;56:421-425 doi:10.1136/ard.56.7.421
  • Extended reports

Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis

  1. Outi Mäki-Ikolaa,
  2. Roger Hällgrenb,
  3. Lars Kanerudc,
  4. Nils Felteliusb,
  5. Lars Knutssond,
  6. Kaisa Granforsa
  1. aNational Public Health Institute, Department in Turku, Turku, Finland , bUniversity Hospital, Department of Internal Medicine, Section of Rheumatology, Uppsala, Sweden , cKarolinska Institute, Stockholm Söder Hospital, Department of Rheumatology, Stockholm, Sweden , dUniversity Hospital, Department of Surgery, Uppsala, Sweden
  1. Dr O Mäki-Ikola, National Public Health Institute, Department in Turku, Kiinamyllynkatu 13, SF-20520 Turku, Finland.
  • Accepted 8 May 1997

Abstract

OBJECTIVE To measure gut immunity directly in jejunal fluid in patients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA).

METHODS Antibodies against three different Enterobacterias were measured in jejunal perfusion fluids (collected by a double balloon perfusion device) of 19 patients with AS, 14 patients with RA, and 22 healthy controls using enzyme linked immunosorbent assay.

RESULTS The AS patients had significantly increased jejunal fluid concentrations of IgM, IgG, and IgA class antibodies against Klebsiella pneumoniae, and IgM and IgA class antibodies against Escherichia coli and Proteus mirabilis compared with healthy controls. When compared with the patients with RA, the AS patients had higher concentrations of IgA and IgG class antibodies only against K pneumoniae. The RA patients had higher IgM class antibody concentrations against all three studied Enterobacterias, when compared with the healthy controls, suggesting an enhanced mucosal immune response in these patients. A three month treatment with sulphasalazine did not decrease enterobacterial antibody concentrations in the 10 patients with AS.

CONCLUSION There is strong direct evidence for an abnormal mucosal humoral immune response particularly to K pneumoniae in patients with AS.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.